ARGUS upgrades Incyte Corp. (Nasdaq: INCY) from Hold to Buy based on valuation and the solid trial results of INCB18424 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE